Background: G-protein activation mediates inhibition of Ntype Ca 2؉ currents. Volatile anesthetics affect G-protein pathways at various levels, and activation of G-proteins has been shown to increase the volatile anesthetic potency for inhibiting the electrical-induced contraction in ileum. The authors investigated whether isoflurane inhibition of N-type Ba 2؉ currents was mediated by G-protein activation.
DUE to their role in neuronal excitability and synaptic transmission, voltage-dependent Ca 2ϩ channels are important targets for volatile anesthetic (VA) action. Blockade of voltage-dependent Ca 2ϩ channels enhances anesthetic potency 1, 2 and N-type blockers act as analgesics, 3, 4 which support the relevance of N-type channels to anesthesia. In dorsal-root ganglia neurons, isoflurane does not inhibit R-type currents, whereas it inhibits T-, L-, N-. and P/Q-current types with IC50 of 0.28, 0.35, 0.68, and 1.46 mM, respectively. 5, 6 However, when expressed in Xenopus oocytes, P/Q-, N-, L-, and R-current types are inhibited to a similar extent by isoflurane. 7 When expressed in Xenopus oocytes, neuronal L-type currents do not display inactivation in both the presence and absence of VAs, 7 whereas L-type currents display inactivation in various neuronal cells. 8 -11 These reports suggest that the response to VA is dependent on the cellular environment, which in turn relates to channel subunit composition and the compliment of regulatory factors involved. To examine the role of G-protein regulation, we chose to study the VA action on N-type Ba 2ϩ currents in a neuronal environment by using the human SH-SY5Y cell line. In these cells, we have previously shown that halothane at clinically relevant concentrations decreased the magnitude, accelerated the inactivation rate, and slowed the activation rate of L-type Ba 2ϩ currents. 11 VAs may specifically affect neuronal intracellular Ca 2ϩ by modulating the function of N-type currents, because these currents are only found in neurons and neurosecretory cells. G-protein activation inhibits N-type Ca 2ϩ currents in every type of neuron yet studied and contributes to the modulation of electrical activity and synaptic function between neighboring neurons. VAs affect G-protein pathways at different levels, [12] [13] [14] [15] [16] and in some cases decreasing the level of G-protein activation lowers the potency of VAs. 17, 18 In this study we investigated whether the VA inhibitory action on N-type Ba 2ϩ currents was mediated by VA actions on G-proteins. Interestingly, we found that G-protein activation in a neuronal environment strongly decreased the isoflurane potency for inhibiting N-type Ba 2ϩ currents and, in turn, isoflurane decreased the G-protein voltage-dependent modulation of N-type Ba 2ϩ currents.
Materials and Methods
The human neuroblastoma SH-SY5Y cells were grown as previously described. 11 For these studies, cells were differentiated with 10 M retinoic acid for 3-6 weeks to increase the expression level of N-type Ca 2ϩ channels. We used Ba 2ϩ as the permeant ion to increase the current magnitude. Exposure to retinoic acid results in cells with extensive processes, which limits the quality of the voltage clamp. To decrease contributions attributable to variable voltage-clamp errors between control and treated groups, we performed control and treated current measurements in the same cells. A two-electrode voltage clamp was used (Dagan 3900; Dagan Corporation, Minneapolis, MN). Ag/AgCl electrodes made direct contact with both aqueous solutions. Output from the voltage clamp amplifier was sent to a microcomputer (12-bit resolution, 125 kHz) data acquisition interface (Labmaster; Axon Intruments, Foster City, CA). 11 The whole cell voltage clamp mode was used. Pipette resistances were 1.6 -4.0 M⍀. The pipette solution contained (in mM) CsCl 120, Mg(ATP) 2 2, EGTA 10, HEPES 10, TEA-Cl 10, pH 7.4. The bath solution contained (in mM) NaCl 110, BaCl 2 10, MgCl 2 2, Glucose 10, HEPES 10, pH 7.4; to it were added 1 M tetrodotoxin and 10 M nitrendipine to block the voltage-dependent Na ϩ and L-type Ca 2ϩ currents, respectively. Under these conditions, over 95% of the voltage-dependent Ba 2ϩ currents were blocked by 500 nM -Conotoxin (type GVIA), an N-type Ca 2ϩ channel blocker (3-5 min exposure). Ba 2ϩ currents were measured by applying two identical sets of depolarizing pulses (50 ms), one before (eliciting the P1 current) and another after a depolarizing conditioning prepulse to ϩ80 mV (eliciting the P2 current). The conditioning prepulse relieves the level of G-proteinmediated voltage-dependent inhibition of N-type Ca 2ϩ currents. 19 Current measurements were done at the end of the P1 and P2 pulses, to eliminate contributions of a small-rapidly inactivating Ba 2ϩ current observed in some cells and only in the P1 currents (not in the P2 currents).
Tetrodotoxin, -Conotoxin, pertussis toxin (PTX), the nonhydrolyzable GTP analog GTP␥S (Guanosine 5'-0-[3-Thiotriphosphate] Tetralithium Salt), and the nonhydrolyzable GDP analog GDP␤S (Guanosine 5'-0-[2-thiodiphosphate] Trilithium Salt) were purchased from Sigma (St. Louis, MO). Cholera toxin (CTX) was purchased from Calbiochem (San Diego, CA). The bath solutions were applied by using syringe pumps with 10-ml glass syringes connected to a Teflon manifold solenoid valve (Cole-Parmer, Niles, IL) that was connected to a 0.24-ml chamber (Model RC-24; Warner Instruments, Hamden, CT) through a tubing with a total dead space of 40 l (15-cm length, ID 0.58 mm). 11 The chamber was filled to about 0.15 ml. Throughout the experiment bath solutions were continuously perfused at a rate of 24 ml/h, except during data acquisition when cells were not perfused to reduce the noise level of the current traces. Isoflurane solutions were prepared on the day of the experiment from a saturated solution prepared by equilibrating buffer over isoflurane overnight at room temperature. The isoflurane concentrations were measured by gas chromatography, in parallel experiments, at 1 min after isoflurane application. Isoflurane concentrations could not measured from the buffer of the cells from which current data were collected, because buffer sampling would disrupt the experiment due to the small volume of our chamber. Bath solutions containing isoflurane were applied for a period of 3 min (corresponding to~7.7 volume changes). Experiments were conducted at room temperature (23-26°C) . At 25°C the hypothetical isoflurane aqueous concentration corresponding to one minimal alveolar anesthetic concentration is 0.47 mM. 20, 21 The membrane capacitance and series resistance were compensated by about 80%. The background conductance was subtracted, but not the residual capacitance transient. During acquisition, current traces were filtered at 10 kHz and digitized at 50 kHz; for data analysis, current traces were filtered at 2 kHz. For figures, the data for current traces was reduced by a factor of 8 (by taking the first of every 8 data points). Data were acquired and analyzed by using Pclamp8 (Axon Instruments, Foster City, CA) and Graph-Pad Prism 2.01 (GraphPad Software Inc. San Diego, CA) software.
We know of no studies describing GABA-A receptors or their Clcurrents in SH-SY5Y cells. Because volatile anesthetics have been shown to increase Clcurrents through activation of GABA-A receptors, 22,20 we tested whether SH-SY5Y cells had functional GABA-A receptors. In SH-SY5Y cells, application of GABA (30 M) directly on top of the cell through a millimanifold (MLF-4 from ALA Scientific, NY; dead space Ͻ 50 l at 2.8 l/sec flow rate) produced no ionic current changes (11 cells, Vh ϭ Ϫ60 mV) ( fig. 1, A) . Identical GABA application on adult rat cultured dorsal root ganglia neurons produced the well-known Clcurrent increase that was reversible on washout in all seven cells tested ( fig. 1, B) . Apparently SH-SY5Y cells do not have detectable functional GABA-A receptors.
In the absence ( fig. 2 , A) and presence (figs. 2, B and C) of GTP␥S, P1 and P2 currents display a decay/rundown on assuming the whole cell conformation; therefore, the isoflurane data were compared with control data collected at equivalent times from initiation of the whole cell conformation. The cells exposed to GTP␥S were allowed to equilibrate for 7 min after whole cell conformation was obtained, and the time interval between collecting control and isoflurane data was the same in the absence and presence of GTP␥S (5 min). During this 5-min period (0 -5 min for non-GTP␥S group, 7-12 min for GTP␥S group), there was a small current decay that was comparable for both groups (Ϯ GTP␥S).
Data Analysis
Comparison between different groups was performed using a two-tailed t test, paired or unpaired depending on the experimental design, by means of Sigma software (Jandel Scientific Corp., San Rafael, CA).
Results

GTP␥S Reduces the Magnitude and Increases the P2/P1 Ratio of N-type Ba 2ϩ Currents in SH-SY5Y Cells
G-protein mediated inhibition of N-type Ba 2ϩ currents was measured by applying two sets of depolarizing pulses, one before (eliciting the P1 current) and the other after a depolarizing prepulse to ϩ80 mV (eliciting the P2 current) ( fig. 3 ). The prepulse to ϩ80 mV, partially relieves the G-protein-mediated voltage-dependent block in the subsequent P2 pulse. 19 The level of the G-protein-mediated voltage-dependent block was mea- sured as the change in the P2/P1 current ratio. 19 In the absence of G-protein activators the magnitude of P1 and P2 currents and kinetics are similar ( fig. 3, A) , suggesting that in the whole cell conformation the level of endogenous G-protein activation is minimal. In fact, similar P2/P1 current ratio values were found in the absence of the G-protein activator GTP␥S ( fig. 3, D, open circles) and in the presence of the G-protein deactivator GDP␤S ( fig. 3, D, open triangles) . In the absence of G-protein activation, the P2 current magnitude tended to be slightly lower than the P1 current magnitude ( fig. 3, A) ; hence, the P2/P1 current ratio was about 0.9 rather than unity ( fig. 3, D, open symbols) . A possible reason for the P2/P1 ratio being lower than unity under these conditions could be due to incomplete removal of N-type current inactivation before measuring the P2-current. In the absence of G-protein activation the P2/P1 current ratio was constant over the observation time ( fig. 3 , D, open symbols), indicating that the P2/P1 current ratio is not affected by the slow rundown of N-type Ba 2ϩ currents ( fig. 2, A) .
Addition of GTP␥S to the pipette solution slowed the activation kinetics of P1 currents with respect to that of P2 currents (figs. 3, B and C, vs. fig. 3, A) , increased the P2/P1 current ratio ( fig. 3, D) , and decreased the N-type Ba 2ϩ current magnitude ( fig. 3, E) in a dose-dependent manner. These effects are characteristic of G-proteinmediated inhibition of N-type currents. 23, 19 The current magnitude in these cells is normally distributed (not shown) and highly variable ( fig. 3, E) . To reduce the effect of this variability when measuring the isoflurane effects, we collected control and isoflurane data from the same cells.
GTP␥S Decreases the Isoflurane Potency for Reducing N-type Ba 2ϩ Currents
In the absence of GTP␥S, 0.3 mM isoflurane decreased the magnitude of N-type Ba 2ϩ currents ( fig. 4, A) without affecting their reversal potential ( fig. 4, B) , which is consistent with the absence of activation of other ionic currents. Isoflurane reduced the N-type Ba 2ϩ currents in a dose-dependent manner with an apparent IC50 of about 0.28 mM for both the P1 and P2 current ( fig. 4 ). Reversal of the isoflurane-induced current reduction was very slow, ranging from 4 -34% after a 3-min washout (corrected for rundown; data not shown).
To investigate the effects of isoflurane in the presence of GTP␥S, we selected 120 M GTP␥S, because at this concentration G-protein activation is not maximal (previous section, fig. 3, E) . Therefore, we could test whether the isoflurane-induced reduction in N-type Ba 2ϩ currents was due to enhancement of G-protein-mediated channel block. Interestingly, we found that in the presence of 120 M GTP␥S, isoflurane at 0.3 mM did not decrease but increased the P1 current magnitude in five out of six cells. The increase in P1 current magnitude was high in some cells ( fig. 4, C) , but on average the increase did not reach statistical significance ( fig. 4, D) . Elimination of the 0.3 mM isoflurane-induced current block and the tendency for isoflurane to increase the current magnitude was also observed in the P2 current (figs. 4, C and E). In the presence of 120 M GTP␥S, isoflurane was approximately~three times less potent in inhibiting N-type Ba 2ϩ currents ( fig. 4, E,squares) . The Control current level at ؉10 mV was considered equal to 0.478, based on population current reduction observed with 120 M GTP␥S (Fig. 3, E) effect of GTP␥S on reducing the isoflurane potency for inhibiting N-type Ba 2ϩ currents was dose-dependent ( fig. 4, F) .
The P2/P1 current ratio was not changed by isoflurane in the absence of GTP␥S ( fig. 5, A) , but it was significantly reduced by isoflurane in the presence of 120 M GTP␥S ( fig. 5, B) . The isoflurane-induced reduction in the P2/P1 current ratio seems to result from a slightly larger increase in the P1 current relative to the P2 current ( fig. 4, C) . The magnitude of the isoflurane-induced reduction in the P2/P1 current ratio values was observed in all cells at ϩ20mV and in most cells at ϩ10mV. In the presence of GTP␥S, the isoflurane reduction in the P2/P1 current ratio was completely reversed after 3 min of washout (data not shown).
Pretreatment with PTX and CTX
To further characterize the nature of the G-proteins involved in the above observations, cells were treated with either PTX or CTX. These toxins affect G-proteins by adenosine diphosphate ribosylating the G␣ subunits at different sites. PTX adenosine diphosphate ribosylates G␣ of "i,o and t types" at a cysteine, which leads to the accumulation of inactive GDP-bound G-proteins, whereas CTX adenosine diphosphate ribosylates G␣ of the "s and olf type" at an arginine, resulting in an initial activation followed by a strong down-regulation (1-8 h) of these G-proteins. 24, 25 Pretreatment with either PTX or CTX reduced the P2/P1 current ratio of cells exposed to GTP␥S, toward baseline values (the value in the absence of GTP␥S) and eliminated the isoflurane-induced reduction in the P2/P1 current ratio ( fig. 6, A) . In contrast, pretreatment with either PTX or CTX did not significantly affect the GTP␥S-evoked protection against the isoflurane-induced reduction of N-type Ba 2ϩ currents ( fig. 6, B) , even though PTX pretreatment resulted in current values resembling those of untreated cells and CTX pretreatment resulted in a~50% current recovery ( fig. 3, E) . These observations indicate that in these cells, G-protein-mediated current reduction (voltage-dependent and voltage-independent) of N-type Ba 2ϩ currents is mediated by PTX/CTX-sensitive G-proteins, whereas CTX/PTX-insensitive G-proteins mediate the decrease in potency of isoflurane in blocking N-type Ba 2ϩ currents.
Discussion
In this study we investigated whether isoflurane inhibition of N-type Ba 2ϩ currents was mediated by isoflurane action on G-proteins, such as an isoflurane-mediated augmentation of G-protein inhibition of N-type Ba 2ϩ currents. We found that isoflurane had two effects on N-type Ba 2ϩ currents that seem to involve different underlying cellular mechanisms. First, isoflurane reduced N-type Ba 2ϩ currents. This effect was considerably reduced on G-protein activation. Second, isoflurane reduced the P2/P1 current ratio only in the presence of G-protein activation.
Isoflurane-induced Reduction of N-type Ba 2ϩ Currents Does Not Require G-protein Activation but Is Strongly Affected by G-protein Activation
Isoflurane reduced N-type Ba 2ϩ currents in the absence of G-protein activation, both in the absence of GTP␥S and in the presence of GDP␤S. Because GDP␤S irreversibly inactivates all G-protein types, it is apparent that isoflurane does not mediate the reduction of N-type Ba 2ϩ currents by increasing the G-protein-mediated inhibition of N-type Ba 2ϩ currents.
Although isoflurane mediates a reduction of N-type Ba 2ϩ currents through a G-protein-independent pathway, we found the isoflurane inhibition of the N-type currents is in turn strongly affected by G-protein activation. Because both G-protein activation and isoflurane reduce N-type Ba 2ϩ currents, it is possible that the apparent reduction of isoflurane potency by GTP␥S is due to competitive reversal of the G-protein block of N-type Ba 2ϩ currents by isoflurane. Against this possibility is the observation that PTX and CTX treatment, respectively, eliminated or reduced the G-protein-mediated N-type Ba 2ϩ current block without eliminating the G-proteinmediated protection against isoflurane-mediated block. In addition, we approached this possibility by using competitive interaction concepts (Appendix). Our cal- culations, based on a competitive interaction of isoflurane and activated G-protein molecules for a single binding site on the N-type channel, predict that in the presence of 120 M GTP␥S, 0.6 mM isoflurane should lead to a N-type Ba 2ϩ current reduction of between 69 -84% (Appendix), but we actually observed only a 35% current block ( fig. 4, E) . These calculations suggest that a competitive interaction cannot explain the GTP␥Sevoked diminution in isoflurane-mediated inhibition of the N-type Ba 2ϩ currents. One of the various alternative possibilities is that the binding of activated G-protein (at a site different from that mediating the increase in P2/P1 current ratio) leads to a conformational change in the channel and a decreased affinity of isoflurane for its binding site on the N-type channel. Another possibility is that even if two completely independent receptor sites are involved in initiating the GTP␥S and isofluraneevoked current reduction, their action has a late common path. In this case, one could expect that isoflurane will not produce the same level of fractional current block in the absence and presence of GTP␥S but rather the same absolute amount of current reduction compared with untreated cells as it was found.
G-protein-mediated modulation of the isoflurane-induced current reduction may occur in some of the other voltage-dependent Ca 2ϩ channels as well. It has been reported that the inhibitory effect of VA on R-type Ca 2ϩ currents is prevented by strong activation of muscarinic receptors. 26 Because muscarinic receptors are G-protein-linked receptors, the underlying mechanism may have some similarities. Differential G-protein modulation may account in part for the different VA potency for blocking various Ca 2ϩ channel types observed in dorsal root ganglia neurons 5, 6 and when expressed in Xenopus oocytes. 7 Conversely, activation of G-proteins has been shown to increase the potency of VA for inhibiting the electrical-induced contraction in ileum. 18 Then G-protein activation may modulate various VA effects, but the direction of the modulation (increase or decrease of the VA potency) might depend on the pathway involved.
Isoflurane Reduces the P2/P1 N-type Current Ratio in the Presence but not the Absence of GTP␥S SH-SY5Y cells express a variety of G-proteins including PTX-and CTX-sensitive and -insensitive types. 27 In the presence of 120 M GTP␥S, PTX pretreatment returned the P2/P1 current ratio to baseline (no GTP␥S), and CTX-treatment lowered the P2/P1 current ratio, suggesting that (in these cells) the voltage-dependent block of N-type currents is mediated by PTX/CTX-sensitive Gproteins. In the presence of either CTX or PTX treatment, isoflurane did not induce an additional decrease in the P2/P1 current ratio, which suggests that isoflurane affects the voltage-dependent action of PTX/CTX-sensitive G-proteins on N-type currents. The isofluraneevoked reduction in the P2/P1 current ratio was accompanied by a tendency for a current magnitude increase (mostly in the P1 current level). The latter might explain the previously reported isoflurane-induced transient augmentation of N-type Ca 2ϩ currents in rat dorsal root Fig. 3, E) . For each cell the first current measurement was done in the absence of isoflurane, then the second current measurement (5 min later) was done either in the absence (open bars) or presence of (filled bars) isoflurane and normalized to their corresponding first measurement. Significant difference between control and isoflurane within each condition was **P < 0.001, unpaired t test. ganglion. 5 Another possibility that we cannot presently rule out is that the reduction in P2/P1 current ratio results from a slowing of the recovery for inactivation of N-type Ba 2ϩ channels in the presence of GTP␥S and isoflurane.
In summary, in the human neuronal SH-SY5Y cell line it was found that isoflurane blocks N-type Ba 2ϩ currents in a G-protein-independent manner (does not require G-protein activation), that this isoflurane-evoked current block is drastically reduced by activation of CTX/PTXinsensitive G proteins, and that isoflurane decreases the CTX/PTX-sensitive G-protein-mediated voltage-dependent block of N-type Ba 2ϩ currents. The differential dependence on G-protein activation and the apparent involvement of different G-protein types, indicate that both of the measured isoflurane effects (current reduction and P2/P1 current ratio reduction) are most likely mediated through different mechanisms. The level of activation of various G-proteins (and corresponding pathways) would be expected to modulate the VA potency between various cell types and in a given cell type between various physiologic states. Whether G-protein activation in the intact organism can lead to an alteration in volatile anesthetic sensitivity must be examined. 
